Dechra Ltd

Mirataz® Transdermal Ointment

Dechra Ltd
$53.06
 
    In Stock
Never forget to order with AutoShip 1st order: View schedule
Optimum Wellness Plan (OWP) Save up to 15% with an Optimum Wellness Plan
info icon info icon Help

Members of OWP receive discounts on select online products. Find out more about OWP.

Save 5% with AutoShip info icon info icon Help

Save more when you choose AutoShip. Learn more about AutoShip >

Prescription required Prescription required info icon info icon Help

Before shipping your prescription, we'll require vet approval and verified pet information. You may purchase prescriptions and refills from the pharmacy of your choice.

Log in to your MyBanfield account to continue your purchase.

Don’t have a MyBanfield account? Start one here
Description
Mirataz (mirtazapine transdermal ointment) for Cats
  • Mirataz is the first and only FDA-approved transdermal medication for the management of weight loss in cats
  • Mirataz increases body weight by 3.9% in as little as 14 days1
  • Mirataz gives you a practical way to manage your cat’s weight loss without administration of oral medication and does not rely on the cat to eat to be medicated
  • Formulated using proprietary Accusorb technology, Mirataz achieves measurable plasma concentrations of mirtazapine in cats2
  • Mirataz was safe both locally and systemically in a clinical study1

INDICATIONS:
Mirataz is indicated for body weight gain in cats with a history of weight loss.

IMPORTANT SAFETY INFORMATION:
Mirataz (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients. Do not use in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves when handling/applying, wash hands after and avoid contact between the treated cat and people or other animals for 2 hours following application. Use with caution in cats with hepatic and kidney disease. Cat’s food intake should be monitored upon discontinuation. Safety has not been evaluated in cats less than 2 kg, less than six months of age or in breeding, pregnant or lactating cats. The most common adverse reactions observed during clinical trials were application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting. Refer to the prescribing information for complete details.

References:
1. Poole M, Quimby JM, Hu T, et al. A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss. J Vet Pharmacol Ther. 2019;42(2):179-188. doi:10.1111/jvp.12738.
2. Buhles W, Quimby JM, Labelle D, et al. Single and multiple dose pharmacokinetics of a novel transdermal ointment in cats. J Vet Pharmacol Ther. 2018;41(5):644-651.

Product sourced directly from the manufacturer or their approved distributor. Guaranteed genuine product backed by the manufacturer.



For
Cats

Drug class
Tetracyclic antidepressant, Transdermal ointment

Ingredients
Active ingredient(s):
Mirtazapine
Inactive ingredients:
Polyethylene Glycol (PEG) 400, PEG 3350, Diethylene Glycol Monoethyl Ether, PEG-8 Caprylic/Capric Glycerides, Oleyl Alcohol, Butylated Hydroxytoluene, Dimethicone, and Dry Flo TS.

Product strength & size
Mirataz contains 20 mg of mirtazapine per gram of ointment (2% w/w) and is supplied in 5-gram aluminum tubes.
Please ensure the selected product and quantity are appropriate for your pet, as recommended by your veterinarian. For current availability, please refer to the product selection above.



Usage
Mirataz should be administered topically as directed by your veterinarian. Please consult your veterinarian before making any changes or discontinuing the prescribed dosing schedule. If you have any questions about the medication or your pet’s treatment plan, please contact your veterinarian.

Manufacturer Dosage and Administration*
Administer topically by applying a 1.5-inch ribbon of ointment (approximately 2 mg/cat) on the inner pinna of the cat's ear once daily for 14 days.
  • Wear disposable gloves when applying Mirataz. Dispose of used gloves after each application.
  • Alternate the daily application of Mirataz between the left and right inner pinna of the ears. Do not administer into the external ear canal. If desired, the inner pinna of the cat's ear may be cleaned by wiping with a dry tissue or cloth immediately prior to the next scheduled dose. If a dose is missed, apply Mirataz the following day and resume daily dosing.
  • To demonstrate the method of administering the dose, the veterinarian or trained personnel at the clinic should apply the first dose in the presence of the owner.
  • To apply Mirataz:
  • Step 1: Wear disposable gloves. Twist cap on tube counterclockwise to open.
  • Step 2: Apply even pressure on tube and squeeze a 1.5-inch line of ointment onto your gloved finger using the measured line on the carton or in this package insert.
  • Step 3: Using your gloved finger, gently rub ribbon of ointment on inside pinna of the cat's ear spreading it evenly over the surface. Dispose of used gloves after each application. If contact with your skin occurs wash thoroughly with soap and warm water.
*Additional information may be provided within the manufacturer’s full Prescribing Information. Always follow your veterinarian’s specific instructions regarding your pet's care.

Storage
  • Store in a cool, dry place at a controlled temperature below 77°F.
  • Keep this and all other medications in a secure location out of the reach of children and animals.
  • Discard within 30 days of first use.
  • Exposure to extreme temperatures, light, or moisture can affect the integrity and effectiveness of medications. Always store this medication properly (e.g., away from the bathroom, kitchen sink, or other damp places), as outlined on the product label.



Side effects
The most common adverse reactions observed during clinical trials were application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting.
Contact your veterinarian immediately if you observe any of the following side effects, as they may indicate that your pet is not responding appropriately to or is experiencing an issue related to this medication:
  • Severe application site reactions
  • Extreme hyperactivity or hyperexcitability
  • Excessive drowsiness
  • Disorientation or decreased coordination
  • Signs of a rare condition called serotonin syndrome (e.g., muscle rigidity or tremors, extreme restlessness/agitation, enlarged pupils)
The information provided above may not encompass all possible side effects. Please notify your veterinarian if your pet experiences any side effects, including those listed above, or if you notice anything unusual.

Precautions
Before using this product, please review the manufacturer’s full Prescribing Information for any relevant warnings and safety precautions.
  • For topical application in cats only. Not for oral or ophthalmic use.
  • Not for human use. Keep this and all other medications out of reach of children and animals.
  • Wear disposable gloves when handling or applying Mirataz to prevent accidental topical exposure.
  • After application, dispose of used gloves and wash hands with soap and water. After application, care should be taken that people or other animals in the household do not come in contact with the treated cat for 2 hours because mirtazapine can be absorbed transdermally and orally.
  • In case of accidental skin exposure, wash thoroughly with soap and warm water. In case of accidental eye exposure, flush eyes with water.
  • In case of accidental ingestion, or if skin or eye irritation occurs, seek medical attention.
  • Upon discontinuation of Mirataz, it is important to monitor your cat's food intake. Your cat's food intake may lessen after discontinuation of mirtazapine transdermal ointment. If food intake diminishes dramatically (>75%) for several days or if your cat stops eating for more than 48 hours, contact your veterinarian.
Do not administer this medication to animals with a known or suspected allergy/hypersensitivity to it or any of its ingredients. Allergic reactions to medications may occur. Please inform Vetsource and your veterinarian if your pet has any known sensitivities or allergies, especially to medications and supplements.
If your pet displays symptoms of an allergic reaction, discontinue therapy and call your veterinarian immediately or seek emergency veterinary attention. Symptoms may include (but are not limited to): swollen lips, tongue, face, or airways; difficulty breathing; agitation; profuse salivation; and widespread hives or itching.

Food and drug interactions
Mirataz should not be given in combination, or within 14 days before or after treatment with a monoamine oxidase inhibitor (MAOI) [e.g. selegiline hydrochloride (L-deprenyl), amitraz], as there may be an increased risk of serotonin syndrome.
Additionally, the following drugs* may also have potential interactions with this medication: alpha-2 agonists (e.g., clonidine), azole antifungals (e.g., ketoconazole), benzodiazepines (e.g., diazepam), beta blockers (e.g., sotalol), blood pressure medications (e.g., telmisartan [Semintra]), calcium channel blockers (e.g., amlodipine,), CNS depressant drugs (e.g., gabapentin, hydroxyzine, opioids), diltiazem, diuretics (e.g., furosemide [Salix]), metoclopramide, ondansetron, phenobarbital, phenothiazines (e.g., acepromazine [PromAce]), SSRIs (e.g., fluoxetine), tramadol, trazodone, tricyclic antidepressants (e.g., amitriptyline), and warfarin.
Please ensure your veterinarian is aware of all medications, supplements, and over-the-counter (OTC) products that your pet is currently using. Your veterinarian may prescribe multiple medications, even if a potential drug interaction may occur. In these instances, your veterinarian may adjust the dosages or monitor more closely. Contact your veterinarian if your pet experiences any unusual reactions when multiple medications and/or supplements are given together.
*The information provided in this product description may not include all possible interactions. Please consult your veterinarian if you have any questions or concerns prior to use.

Adverse reactions
If you are concerned that your pet has experienced an adverse reaction to this medication, please contact Dechra Veterinary Products at (866) 933-2472 or Vetsource Pet Owner Care at 877-738-4443.

Overdose
If you have any reason to suspect accidental ingestion or overdose, call your doctor/veterinarian or the appropriate poison control resource immediately.
For humans:
  • The national toll-free Poison Help line, 1-800-222-1222, will connect you to your local poison center in case of emergency. This service is available nationwide and in most U.S. territories.
For animals:
  • The ASPCA Animal Poison Control Center is available 24 hours a day, 365 days a year at 888-426-4435.
  • Pet Poison Helpline also provides a 24/7 animal poison control service at 855-764-7661.
Please note: The contact information provided above is for third-party services in the event of a potential poison-related emergency. Consultation fees may apply for these services.


Disclaimer: The content provided on this page is NOT medical advice.
All content, including the images and product description above, is intended for general informational purposes only and should not be considered a substitute for professional veterinary consultation, diagnosis, or treatment. For additional information about this product and how it fits into your pet's individual treatment plan, please consult your veterinarian.

Last revised: 11/12/2026
$53.06
    In Stock